<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png"/></p>
<p>Tilray Brands 的股价在今年持续下跌，目前交易价格已降至去年 7 月以来的最低水平。它最近失去了关键支撑位 5.95 美元，较去年 10 月的最高点下跌超过 76%。那么，现在买入是否安全呢？</p>
<h2>Tilray Brands 股票因风险上升而暴跌</h2>
<p>TLRY 股票本周暴跌，目前已降至去年 7 月以来的最低水平。这一下降在司法部宣布将重新安排大麻的消息后加速。此前，特朗普总统在 1 月发布了一项行政命令。</p>
<p>美国缉毒局（DEA）将于今年 6 月 29 日就这些变更举行首次听证会。如果这一过程顺利完成，将会显著改变行业，使公司运营变得更加容易。</p>
<p>然而，该过程仍面临一些重大风险，包括诉讼，例如 “智能大麻方法”（SAM）组织。该禁毒组织认为，放宽限制违反了联邦法律，并且会对公共健康造成危害。</p>
<p>因此，正在进行的法律行动可能会在长期内延迟重新安排的过程。例如，乔·拜登试图改变分类的努力面临重大延迟，他在完成之前就已卸任总统。</p>
<p>成功的重新安排将对这个面临多重联邦障碍的 500 亿美元行业是个好消息。FDA 批准的大麻产品将被移至低至中等滥用潜力的类别。</p>
<p>Tilray Brands 销售多种产品，如 Mollo、Good Supply 和 Redecan，在美国并没有主要市场。它在包括加拿大和德国在内的 20 多个国家销售其产品。</p>
<p>管理层一直指出美国的监管挑战，在美国，大麻被归类为受控物质产品。它指出一旦监管环境改变，可能会进入美国市场。该公司最近表示：</p>
<p>“Tilray 准备与监管机构和医疗保健提供者合作，负责任地扩大医疗大麻的获取，并帮助塑造美国这一行业的未来。”</p>
<h2>饮料业务仍在挣扎</h2>
<p>Tilray Brands 通过收购不断扩大其业务。具体来说，它花费数百万美元从 AB InBev 和 Molson Coors 等公司购买饮料品牌。其目标是成为酒精业务的主要参与者。</p>
<p>然而，全球啤酒消费下降的迹象表明，该业务仍在挣扎。例如，最近的财务结果显示，其饮料收入在第三季度降至 4260 万美元，而去年同期的收入超过 5590 万美元。此外，毛利率持续下降，降至 32%。</p>
<p>由于全球啤酒消费增长停滞，该部门可能仍将面临压力。数据显示，全球啤酒市场目前为 9860 亿美元，预计在未来几年将逐渐增长，到 2032 年达到 1.3 万亿美元。</p>
<h2>Tilray Brands 股价技术分析</h2>
<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png"/></p>
<p><em>TLRY 股票图表 | 来源：</em> <em>TradingView</em></p>
<p>日线图显示，TLRY 股价在过去几个月中暴跌。从 4 月的 9.30 美元降至今天的 5.41 美元，创下数月来的最低水平。</p>
<p>该股票最近跌破了关键支撑位 5.98 美元，这是今年 3 月的最低水平。跌破该水平确认了看跌前景。</p>
<p>不过，该股票尚未超卖，相对强弱指数（RSI）交易在 33，为 3 月 31 日以来的最低水平。因此，TLRY 股价在短期内可能还有进一步下跌的空间，可能会低于 5 美元。</p>
<p>本文首次出现在 Invezz 上，标题为 “Tilray Brands 股票正在自由下跌：关键原因及接下来会发生什么”</p>

TLRY

<p>Tilray Brands 的股票正在经历显著下跌，目前交易价格为去年七月以来的最低点，比十月的峰值下跌超过 76%。在司法部宣布重新安排大麻的消息后，股价下跌加速，该政策面临法律挑战。尽管重新安排可能带来潜在好处，但 Tilray 的饮料部门正面临收入下降的困境。股票的技术分析显示进一步下行的潜力，价格最近跌破了关键支撑位</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png" alt="" original-src="https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png"/></p>
<p>Tilray Brands stock price remains in a freefall this year and is now trading at its lowest level since July 9 last year. It recently lost the crucial support level at $5.95, and is down by over 76% from its highest point in October last year. So, is it safe to buy the dip?</p>
<div class="lb-trans"><p>Tilray Brands 的股价在今年持续下跌，目前交易价格已降至去年 7 月以来的最低水平。它最近失去了关键支撑位 5.95 美元，较去年 10 月的最高点下跌超过 76%。那么，现在买入是否安全呢？</p>
</div><h2>Tilray Brands stock has crashed amid rising risks</h2>
<div class="lb-trans"><h2>Tilray Brands 股票因风险上升而暴跌</h2>
</div><p>TLRY stock has plunged this week and is now at its lowest level since July last year. This retreat accelerated after the Justice Department announced that it would reschedule cannabis. This followed an executive order by President Donald Trump in January.</p>
<div class="lb-trans"><p>TLRY 股票本周暴跌，目前已降至去年 7 月以来的最低水平。这一下降在司法部宣布将重新安排大麻的消息后加速。此前，特朗普总统在 1 月发布了一项行政命令。</p>
</div><p>The DEA will hold its first hearing on these changes on June 29 this year regarding the rescheduling. If the process concludes and is successful, it will dramatically change the industry by making it easier for companies to operate.</p>
<div class="lb-trans"><p>美国缉毒局（DEA）将于今年 6 月 29 日就这些变更举行首次听证会。如果这一过程顺利完成，将会显著改变行业，使公司运营变得更加容易。</p>
</div><p>However, the process still faces some major risks, including lawsuits, including the Smart Approaches to Marijuana (SAM). The group of prohibitionists argued that loosening restrictions violates federal law. It also argues that it will be harmful to public health.</p>
<div class="lb-trans"><p>然而，该过程仍面临一些重大风险，包括诉讼，例如 “智能大麻方法”（SAM）组织。该禁毒组织认为，放宽限制违反了联邦法律，并且会对公共健康造成危害。</p>
</div><p>Therefore, there is a likelihood that the ongoing legal actions will delay the rescheduling process in the long-term. For example, Joe Biden’s attempts to change the classification faced substantial delays and he exited the presidency before it was completed.</p>
<div class="lb-trans"><p>因此，正在进行的法律行动可能会在长期内延迟重新安排的过程。例如，乔·拜登试图改变分类的努力面临重大延迟，他在完成之前就已卸任总统。</p>
</div><p>A successful rescheduling will be a good thing for the $50 billion industry that has faced multiple barriers at the federal level. Marijuana products approved by the FDA will be moved to a category with low to moderate potential abuse.</p>
<div class="lb-trans"><p>成功的重新安排将对这个面临多重联邦障碍的 500 亿美元行业是个好消息。FDA 批准的大麻产品将被移至低至中等滥用潜力的类别。</p>
</div><p>Tilray Brands, which sells several products like Mollo, Good Supply, and Redecan, does not have a major presence in the United States. It instead sells its products in over 20 countries, including in Canada and Germany.</p>
<div class="lb-trans"><p>Tilray Brands 销售多种产品，如 Mollo、Good Supply 和 Redecan，在美国并没有主要市场。它在包括加拿大和德国在内的 20 多个国家销售其产品。</p>
</div><p>The management has always pointed to the regulatory challenges in the US, where cannabis has been classified as a controlled substance product. It has pointed to a potential entry to the US once the regulatory environment changes. The company recently said:</p>
<div class="lb-trans"><p>管理层一直指出美国的监管挑战，在美国，大麻被归类为受控物质产品。它指出一旦监管环境改变，可能会进入美国市场。该公司最近表示：</p>
</div><p>“Tilray stands ready to partner with regulators and healthcare providers to responsibly expand access to medical cannabis and help shape the future of this industry in the United States.”</p>
<div class="lb-trans"><p>“Tilray 准备与监管机构和医疗保健提供者合作，负责任地扩大医疗大麻的获取，并帮助塑造美国这一行业的未来。”</p>
</div><h2>Beverage business is still struggling</h2>
<div class="lb-trans"><h2>饮料业务仍在挣扎</h2>
</div><p>Tilray Brands has been growing its business through acquisitions. Precisely, it has spent millions of dollars buying beverage brands from companies like AB InBev and Molson Coors. Its goal is to become a major player in the alcohol business.</p>
<div class="lb-trans"><p>Tilray Brands 通过收购不断扩大其业务。具体来说，它花费数百万美元从 AB InBev 和 Molson Coors 等公司购买饮料品牌。其目标是成为酒精业务的主要参与者。</p>
</div><p>However, there are signs that the business is still struggling as beer consumption drops globally. For example, the most recent financial results revealed that its beverage revenue dropped to $42.6 million in the third quarter. It had made over $55.9 million in revenue in the same period a year earlier. Also the gross margin continued falling, reaching 32%.</p>
<div class="lb-trans"><p>然而，全球啤酒消费下降的迹象表明，该业务仍在挣扎。例如，最近的财务结果显示，其饮料收入在第三季度降至 4260 万美元，而去年同期的收入超过 5590 万美元。此外，毛利率持续下降，降至 32%。</p>
</div><p>The division will likely remain under pressure as global beer consumption growth stalls. Data shows that the global beer market stood at $986 billion today, and is expected to grow gradually in the coming years to hit $1.3 trillion by 2032.</p>
<div class="lb-trans"><p>由于全球啤酒消费增长停滞，该部门可能仍将面临压力。数据显示，全球啤酒市场目前为 9860 亿美元，预计在未来几年将逐渐增长，到 2032 年达到 1.3 万亿美元。</p>
</div><h2>Tilray Brands stock price technical analysis</h2>
<div class="lb-trans"><h2>Tilray Brands 股价技术分析</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png" alt="" original-src="https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png"/></p>
<p><em>TLRY stock chart | Source:</em> <em>TradingView</em></p>
<div class="lb-trans"><p><em>TLRY 股票图表 | 来源：</em> <em>TradingView</em></p>
</div><p>The daily chart reveals that the TLRY stock price has crashed in the past few months. It has dropped from $9.30 in April to $5.41 today, its lowest level in months.</p>
<div class="lb-trans"><p>日线图显示，TLRY 股价在过去几个月中暴跌。从 4 月的 9.30 美元降至今天的 5.41 美元，创下数月来的最低水平。</p>
</div><p>The stock recently plunged below the key support level at $5.98, its lowest level in March this year. Moving below that level confirmed the bearish outlook.</p>
<div class="lb-trans"><p>该股票最近跌破了关键支撑位 5.98 美元，这是今年 3 月的最低水平。跌破该水平确认了看跌前景。</p>
</div><p>Still, the stock is not yet oversold, with the Relative Strength Index (RSI) trading at 33, its lowest level since March 31st. Therefore, the TLRY share price has more downside to go in the near term, potentially below $5.</p>
<div class="lb-trans"><p>不过，该股票尚未超卖，相对强弱指数（RSI）交易在 33，为 3 月 31 日以来的最低水平。因此，TLRY 股价在短期内可能还有进一步下跌的空间，可能会低于 5 美元。</p>
</div><p>The post Tilray Brands stock is in a freefall: key reasons and what next appeared first on Invezz</p>
<div class="lb-trans"><p>本文首次出现在 Invezz 上，标题为 “Tilray Brands 股票正在自由下跌：关键原因及接下来会发生什么”</p>
</div>

Tilray Brands 的股票正在急剧下跌：关键原因及未来走势